Literature DB >> 25093698

Biglycan deficiency: increased aortic aneurysm formation and lack of atheroprotection.

Tao Tang1, Joel C Thompson1, Patricia G Wilson1, Meghan H Yoder1, Julia Müeller2, Jens W Fischer2, Kevin Jon Williams3, Lisa R Tannock4.   

Abstract

Proteoglycans of the arterial wall play a critical role in vascular integrity and the development of atherosclerosis owing to their ability to organize extracellular matrix molecules and to bind and retain atherogenic apolipoprotein (apo)-B containing lipoproteins. Prior studies have suggested a role for biglycan in aneurysms and in atherosclerosis. Angiotensin II (angII) infusions into mice have been shown to induce abdominal aortic aneurysm development, increase vascular biglycan content, increase arterial retention of lipoproteins, and accelerate atherosclerosis. The goal of this study was to determine the role of biglycan in angII-induced vascular diseases. Biglycan-deficient or biglycan wildtype mice crossed to LDL receptor deficient (Ldlr-/-) mice (C57BL/6 background) were infused with angII (500 or 1000ng/kg/min) or saline for 28days while fed on normal chow, then pumps were removed, and mice were switched to an atherogenic Western diet for 6weeks. During angII infusions, biglycan-deficient mice developed abdominal aortic aneurysms, unusual descending thoracic aneurysms, and a striking mortality caused by aortic rupture (76% for males and 48% for females at angII 1000ng/kg/min). Histological analyses of non-aneurysmal aortic segments from biglycan-deficient mice revealed a deficiency of dense collagen fibers and the aneurysms demonstrated conspicuous elastin breaks. AngII infusion increased subsequent atherosclerotic lesion development in both biglycan-deficient and biglycan wildtype mice. However, the biglycan genotype did not affect the atherosclerotic lesion area induced by the Western diet after treatment with angII. Biglycan-deficient mice exhibited significantly increased vascular perlecan content compared to biglycan wildtype mice. Analyses of the atherosclerotic lesions demonstrated that vascular perlecan co-localized with apoB, suggesting that increased perlecan compensated for biglycan deficiency in terms of lipoprotein retention. Biglycan deficiency increases aortic aneurysm development and is not protective against the development of atherosclerosis. Biglycan deficiency leads to loosely packed aortic collagen fibers, increased susceptibility of aortic elastin fibers to angII-induced stress, and up-regulation of vascular perlecan content. Published by Elsevier Ltd.

Entities:  

Keywords:  Aortic aneurysms; Atherosclerosis; Elastin; Extracellular matrix; Proteoglycans

Mesh:

Substances:

Year:  2014        PMID: 25093698      PMCID: PMC4169288          DOI: 10.1016/j.yjmcc.2014.07.014

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  34 in total

Review 1.  Developmental basis of vascular smooth muscle diversity.

Authors:  Mark W Majesky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-03-22       Impact factor: 8.311

2.  Biglycan deficiency causes spontaneous aortic dissection and rupture in mice.

Authors:  Anne-Marie Heegaard; Alessandro Corsi; Carl Christian Danielsen; Karina L Nielsen; Henrik L Jorgensen; Mara Riminucci; Marian F Young; Paolo Bianco
Journal:  Circulation       Date:  2007-05-14       Impact factor: 29.690

3.  Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice.

Authors:  T Xu; P Bianco; L W Fisher; G Longenecker; E Smith; S Goldstein; J Bonadio; A Boskey; A M Heegaard; B Sommer; K Satomura; P Dominguez; C Zhao; A B Kulkarni; P G Robey; M F Young
Journal:  Nat Genet       Date:  1998-09       Impact factor: 38.330

4.  Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration.

Authors:  Yutaka Nakashima; Hiroshi Fujii; Shinji Sumiyoshi; Thomas N Wight; Katsuo Sueishi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-02-15       Impact factor: 8.311

5.  Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Thomas Thom; Nancy Haase; Wayne Rosamond; Virginia J Howard; John Rumsfeld; Teri Manolio; Zhi-Jie Zheng; Katherine Flegal; Christopher O'Donnell; Steven Kittner; Donald Lloyd-Jones; David C Goff; Yuling Hong; Robert Adams; Gary Friday; Karen Furie; Philip Gorelick; Brett Kissela; John Marler; James Meigs; Veronique Roger; Stephen Sidney; Paul Sorlie; Julia Steinberger; Sylvia Wasserthiel-Smoller; Matthew Wilson; Philip Wolf
Journal:  Circulation       Date:  2006-01-11       Impact factor: 29.690

6.  Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins.

Authors:  K D O'Brien; K L Olin; C E Alpers; W Chiu; M Ferguson; K Hudkins; T N Wight; A Chait
Journal:  Circulation       Date:  1998-08-11       Impact factor: 29.690

7.  Retrovirally mediated overexpression of glycosaminoglycan-deficient biglycan in arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointimae after vascular injury.

Authors:  Jin-Yong Hwang; Pamela Y Johnson; Kathleen R Braun; Aleksander Hinek; Jens W Fischer; Kevin D O'Brien; Barry Starcher; Alexander W Clowes; Mervyn J Merrilees; Thomas N Wight
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

8.  Biglycan is required for adaptive remodeling after myocardial infarction.

Authors:  D Westermann; J Mersmann; A Melchior; T Freudenberger; C Petrik; L Schaefer; R Lüllmann-Rauch; O Lettau; C Jacoby; J Schrader; S-M Brand-Herrmann; M F Young; H P Schultheiss; B Levkau; H A Baba; T Unger; K Zacharowski; C Tschöpe; J W Fischer
Journal:  Circulation       Date:  2008-02-25       Impact factor: 29.690

9.  Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development.

Authors:  Fei Huang; Joel C Thompson; Patricia G Wilson; Hnin H Aung; John C Rutledge; Lisa R Tannock
Journal:  J Lipid Res       Date:  2007-11-21       Impact factor: 5.922

10.  Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway.

Authors:  Delphine Gomez; Ayman Al Haj Zen; Luciano F Borges; Monique Philippe; Paulo Sampaio Gutierrez; Guillaume Jondeau; Jean-Baptiste Michel; Roger Vranckx
Journal:  J Pathol       Date:  2009-05       Impact factor: 7.996

View more
  13 in total

1.  Elevated circulating TGF-β is not the cause of increased atherosclerosis development in biglycan deficient mice.

Authors:  Joel C Thompson; Patricia G Wilson; Alex P Wyllie; Adrian K Wyllie; Lisa R Tannock
Journal:  Atherosclerosis       Date:  2017-11-10       Impact factor: 5.162

Review 2.  The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis.

Authors:  A Hultgårdh-Nilsson; J Borén; S Chakravarti
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

3.  Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-β inhibition.

Authors:  Patricia G Wilson; Joel C Thompson; Meghan H Yoder; Richard Charnigo; Lisa R Tannock
Journal:  J Lipid Res       Date:  2017-09-14       Impact factor: 5.922

Review 4.  A role for proteoglycans in vascular disease.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2018-02-27       Impact factor: 11.583

5.  Vascular proteoglycans and atherosclerosis: not over yet.

Authors:  Lisa R Tannock
Journal:  Atherosclerosis       Date:  2014-09-28       Impact factor: 5.162

6.  Biglycan Intensifies ALK5-Smad2/3 Signaling by TGF-β1 and Downregulates Syndecan-4 in Cultured Vascular Endothelial Cells.

Authors:  Takato Hara; Eiko Yoshida; Yasuhiro Shinkai; Chika Yamamoto; Yasuyuki Fujiwara; Yoshito Kumagai; Toshiyuki Kaji
Journal:  J Cell Biochem       Date:  2017-01-10       Impact factor: 4.429

7.  ADAMTS proteases in cardiovascular physiology and disease.

Authors:  Salvatore Santamaria; Rens de Groot
Journal:  Open Biol       Date:  2020-12-23       Impact factor: 6.411

Review 8.  Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological significance.

Authors:  Sandeep Appunni; Muni Rubens; Venkataraghavan Ramamoorthy; Vivek Anand; Madhuram Khandelwal; Alpana Sharma
Journal:  Mol Cell Biochem       Date:  2021-06-28       Impact factor: 3.396

Review 9.  Diabetes and aortic aneurysm: current state of the art.

Authors:  Juliette Raffort; Fabien Lareyre; Marc Clément; Réda Hassen-Khodja; Giulia Chinetti; Ziad Mallat
Journal:  Cardiovasc Res       Date:  2018-11-01       Impact factor: 10.787

Review 10.  Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia.

Authors:  Amanda L Trout; Ibolya Rutkai; Ifechukwude J Biose; Gregory J Bix
Journal:  Int J Mol Sci       Date:  2020-01-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.